Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bridging Study to Evaluate Safety of ComBe Five (Liquid) (Combined Pentavalent DTwP-rHepB-Hib Vaccine) Made in India, in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks

NCT02904213 is registered in ClinicalTrials.gov with Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products as lead sponsor.

NCT NCT02904213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02904213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bridging Study to Evaluate Safety of ComBe Five (Liquid) (Combined Pentavalent DTwP-rHepB-Hib Vaccine) Made in India, in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks
Lead sponsor
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2016
Completion date
June 24, 2017
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety, pentavalent vaccine